Breaking AI & Tech News Analyzed

The UK automotive market has reached a pivotal moment in its shift towards electric vehicles (EVs), as the average price of new electric cars has fallen to £42,620, making them £785 cheaper than their petrol counterparts, which average at £43,405. This development is a significant milestone in Britain's transition away from fossil fuels, with the higher upfront cost of electric vehicles being a major deterrent for many drivers. However, with total running costs for electric cars being lower for some time, the decrease in upfront costs is expected to drive increased adoption. The decrease in electric car prices can be attributed to several factors, including the electric car grant introduced last summer, which offers up to £3,750 off certain models, and the influx of Chinese competitors that have been able to undercut traditional brands. Carmakers have also been under pressure to meet electric car targets, known as the zero emission vehicle (ZEV) mandate. According to Bex Kennett, head of new car at Autotrader, the electric car market is becoming increasingly competitive, with manufacturers and retailers working hard to improve both the supply and affordability of new electric vehicles. The recent rise in petrol and diesel prices due to the war in Iran has also contributed to increased inquiries for electric cars from consumers looking to cut their energy costs. Gurjeet Grewal, chief executive of Octopus Electric Vehicles, noted that this milestone removes one of the biggest barriers to switching to electric vehicles, as they are now cheaper than petrol cars on upfront cost and have long been cheaper to run. With growing competition and more choice, electric vehicles are becoming the obvious option for drivers. Despite this progress, the transition to electric cars in the UK still faces some barriers, particularly for households without driveways that rely on the public charging network, which remains patchy in some areas.

The Chisenhale Gallery in London greets visitors with an unsettling aroma that oscillates between sweet butter and a harsh, chemical perfume, immediately signalling that the exhibition is designed to disturb both mind and nostrils.At the heart of the show stands a massive mobile health unit – a former US‑British field ambulance acquired at a military auction. Its presence transforms the pastel‑painted gallery into a simulated triage zone, complete with faded chemical warnings, triage forms and evacuation maps. Among the discarded paperwork, a single sheet reveals that the vehicle participated in decontamination after the 2018 Novichok attack on double‑agent Sergei Skripal, adding a chilling historical layer to the installation.The surrounding walls are coated in Baker‑Miller pink, the hue once tested in US jails to calm aggressive inmates. This “drunk‑tank pink” juxtaposes the sterile pink of the health unit, blurring the line between soothing and coercive environments.Beyond visual cues, the exhibition assaults the senses with a bespoke scent concoction. Crowther blends substances derived from powdered milk – a symbol of industrialised sustenance – with hexadecanal, a naturally occurring skin compound known to dampen aggression in men while provoking it in women, and famously emitted by newborns. The result is a “sweetly putrid” odor that feels both familiar and alien, prompting visitors to question whether they are inhaling rubber, milk, or something more sinister.Through this multisensory tableau, Crowther frames colour and smell as potential psy‑ops, probing how basic human experiences can be industrialised and militarised. She asks: What does health mean when it is administered by the state or corporate entities? Who truly benefits when care becomes a tool of surveillance and control?Visitors navigate a space that oscillates between comfort and exploitation, leaving them to wonder whether they are being nurtured or manipulated. The exhibition runs at Chisenhale Gallery until 14 June 2026, inviting the public to confront the uneasy overlap of medical aid, military apparatus and sensory manipulation.

From my home in Hawai‘i, the reef is more than a backdrop—it feeds families, shields shorelines, and anchors our culture. Today that vital connection is under unprecedented threat. Scientists report the most extensive coral‑bleaching episode ever recorded, persisting for 33 months into 2025. At a projected 1.5 °C rise in global temperatures, the IPCC warns that up to 90% of the world’s coral reefs could disappear. That temperature threshold is not a distant projection; it is looming now. Even if climate targets are eventually met, reefs continue to be battered by plastic waste, coastal development, agricultural runoff, and overfishing. Their degradation weakens natural storm barriers, leaving coastal communities more vulnerable to floods and erosion, jeopardising homes, jobs, and cultural heritage. In Hawai‘i we speak of kuleana—a generational duty to protect what sustains us. That principle must expand to every person on the planet: caring for reefs is caring for ourselves. On the ground, communities in French Polynesia have shown that, when equipped with the right tools, they can actively restore damaged reefs. Likewise, my collaboration with the Global Fund for Coral Reefs and the UN Environment Programme demonstrates how targeted financing can create sustainable livelihoods, boost marine conservation, and help coastal societies rebound after extreme weather. Time, however, is not on our side. The next twelve months could become a defining turning point for coral ecosystems. New scientific findings and a series of high‑profile gatherings—including the Kenya Ocean Conference, the International Coral Reef Symposium in New Zealand, and the upcoming Global Coral Reef Summit—will focus world attention on reef survival. The responsibility now lies with governments, businesses, and individuals alike. Proven actions include: cutting carbon footprints, eliminating plastic leakage, protecting keystone species, supporting reef‑positive enterprises, investing in resilient coastal economies, enacting protective legislation, and amplifying public advocacy. Moments like 2026 are not just about pledges; they are about swift, measurable change. Coral reefs cannot wait for perfect plans—they need us to act now, embodying the spirit of kuleana for the sake of our children and the ocean that sustains us. Jason Momoa is an actor, filmmaker, and UNEP Advocate for Life Below Water, dedicated to protecting oceans and raising global awareness of coral‑reef conservation.

The cyberpunk genre is renowned for its arresting imagery, with petroleum flares illuminating the perpetually rainy landscapes of movies like Blade Runner. Replaced, a new 2D action-platformer from Belarus-based Sad Cat Studios, adopts a similar visual style but with a unique twist: it incorporates softly diffusing sepia and warm primary colours, creating a comforting rather than ominous atmosphere.The game's story follows Warren, a scientist who merges with a powerful AI, becoming a man-machine entity. The gameplay involves platforming and combat, but the article notes that Replaced relies heavily on familiar action-platformer tropes in its early stages. However, as the game progresses, it introduces a refugee encampment with a more relaxed pace, allowing players to explore and interact with the environment.Despite its beautiful visuals, Replaced's generic irradiated wilds often detract from the experience. The game's most memorable section involves sneaking back into a heavily guarded facility, where the atmosphere and tension are palpable. This section stands out for its powerful evocation of real-world issues, such as the Mexico-US border wall and the West Bank barrier.Replaced is now available for £16.99/$19.99, offering a unique blend of cyberpunk nostalgia and action-platforming gameplay, albeit with some familiar flaws.

Richard Desmond, the media tycoon and former proprietor of the Daily Express and Channel 5, has lost his claim for up to £1.3bn in damages against the Gambling Commission. The claim was related to the regulator's decision not to award him the 10-year licence to run the national lottery.Desmond's companies, Northern & Shell investment company and the New Lottery Company, had launched a legal action against the Gambling Commission in 2022, arguing that the commission made 'manifest errors' in the process governing the UK's largest public sector contract, worth £6.5bn. The legal process was lengthy, with Desmond's costs estimated to have reached £55m by May last year.The media mogul claimed the commission's mistakes caused him to incur £17.5m of needless costs in pursuing his bid. However, he was also seeking up to £1.3bn in damages to reflect hypothetical lost earnings from running the lottery.The licence was ultimately awarded to Allwyn, a new vehicle owned by Czech billionaire Karel Komárek, which has been running the draw since 2024. On Friday, Mrs Justice Smith dismissed Desmond's claim, stating that the claimants had failed to make out any case of 'manifest error' on the part of the commission.The competition for the award of the fourth licence was found to have reached a lawful outcome. Desmond had previously failed with a separate claim that Allwyn had received an unlawful £70m marketing subsidy from the Gambling Commission.

Angelina Jolie leads the new fashion‑driven drama Couture, bringing a rare level of personal honesty by confronting a storyline that mirrors her own double mastectomy performed to prevent breast cancer. While her performance is undeniably courageous, the film’s overall execution falls short of its ambitions.The plot follows Maxine, an American indie filmmaker (Jolie) who arrives in Paris to direct the opening short for a prestigious runway show. She discovers, through a compassionate doctor played by Vincent Lindon, that a recent biopsy confirms she has breast cancer, forcing her to consider postponing or abandoning her next project. Jolie conveys the shock and denial with subtlety, yet the script, penned by director Alice Winocour, often lapses into glib dialogue that undermines the emotional weight of the situation.Supporting characters include Ada, a fledgling South Sudanese model (Anyier Anei), makeup‑artist‑turned‑writer Angèle (Ella Rumpf), and the brooding first‑assistant director Anton (Louis Garrel). Their subplots—most notably Ada’s ankle injury that threatens the runway performance—remain underdeveloped, serving more as decorative set‑pieces than integral narrative threads.Visually, the film captures the glamour of Parisian haute couture with polished cinematography, yet this sheen accentuates the story’s lack of depth. The fashion world is presented with a “precious” aesthetic that feels specious, offering little insight beyond surface‑level allure.Despite these shortcomings, Jolie’s star power shines through. Her willingness to align a fictional role with a deeply personal health battle adds a layer of authenticity that the surrounding screenplay fails to sustain. ‘Couture’ will be available on digital platforms from 20 April, offering audiences a chance to appreciate Jolie’s performance even if the film’s broader ambitions remain unfulfilled.

Christine Baranski, known for her TV roles in The Good Fight and The Gilded Age, is set to make her West End debut in a revival of Noël Coward's comedy Hay Fever. She will star as Judith Bliss, a newly retired actor, alongside Richard E Grant, who will play her novelist husband.Baranski, a two-time Tony award winner for best featured actress in a play, expressed her excitement to “tear a passion to tatters” in the 1925 play about a family toying with their guests at a country house party. The production, directed by Emily Burns, will run at Wyndham’s theatre from 22 September to 12 December.Baranski described the play as a “101-year-old comedy of appalling manners” that requires “quicksilver delivery and suave flamboyance.” She also praised Grant as “whip-smart and wickedly funny.” This production marks a significant return to the theatre for Grant, who has recently appeared in supporting roles in films like The Thursday Murder Club and Nuremberg.The revival of Hay Fever is part of a recent surge in productions of Noël Coward's works, including Fallen Angels and Easy Virtue. Baranski's West End debut is a long-awaited event, with the actress having attended her first West End play in 1971 as a student at Juilliard.

The musical Avenue Q has returned to the West End, bringing with it its unique blend of provocative puppetry, satire, and catchy songs. The show, which first debuted 20 years ago, has been updated to include modern references to AI, OnlyFans, and Spotify.Directed by Jason Moore, the production features a cast of actor-puppeteers, including Noah Harrison and Emily Benjamin, who bring to life a cast of lovable but flawed characters. The show's puppet designer, Rick Lyon, has created a cast of furry, Sesame Street-inspired characters that are both cute and subversive.The show's songs, written by Robert Lopez and Jeff Marx, are a highlight of the production, with numbers like If You Were Gay and Everyone's a Little Bit Racist tackling taboo subjects with humor and wit. The show's book, written by Jeff Whitty, has been updated to include modern references, adding to the show's timeless satire.While the story itself may not be especially strong, the production's sweet/subversive/manic charms make up for it. The show ends on a hopeful note, with a message that this too will pass, even for Trump.The production is running at the Shaftesbury theatre in London until 29 August.

Modern combat has been reshaped by the Russia‑Ukraine war, the Gaza clashes, India‑Pakistan skirmishes and the recent US‑Israel strikes on Iran, driving an unprecedented global appetite for drones, missiles and sophisticated air‑defence systems. Turkey, a leading military power in the Middle East, is positioning itself as a key supplier in this booming market. At the heart of Turkey’s push is Roketsan, a firm founded in 1988 to equip the Turkish Armed Forces. Today the company exports to roughly 50 nations and is counted among the fastest‑growing defence enterprises worldwide. Bypassing Western embargoes has been a catalyst for this growth. After the United States imposed CAATSA sanctions in 2020 and removed Turkey from the F‑35 programme, Ankara was forced to develop an indigenous defence ecosystem. The result is a network of nearly 4,000 small and medium‑sized enterprises that now supplies over 90 % of the components used in Turkish weapons. Financially, the strategy is paying off. In 2025 Turkish defence exports reached $10 billion. Roketsan’s General Manager Murat Ikinci told Al Jazeera the firm sits at 71st place among global defence firms and is targeting a climb into the top 50, then top 20, and ultimately the top 10 by the end of the decade. To fuel this ambition, President Recep Tayyip Erdoğan inaugurated a suite of new facilities last week, including: Europe’s largest warhead production plant. A new R&D centre employing 1,000 engineers. The “Kirikkale” complex dedicated to rocket‑fuel research. Infrastructure for mass‑producing ballistic and cruise missiles. The construction represents a $1 billion outlay, with an additional $2 billion earmarked for scaling up production capacity. Roketsan’s R&D engine—the third‑largest in Turkey with 3,200 engineers—draws heavily on lessons from ongoing wars. The Ukraine conflict highlighted the effectiveness of cheap FPV and AI‑guided kamikaze drones, prompting Roketsan to field systems such as the ALKA and BURC air‑defences and the laser‑guided CIRIT missile. Recent US‑Israel operations against Iran have underscored the threat posed by low‑cost Iranian‑designed Shahed drones, now upgraded with Russian “Kometa‑B” anti‑jamming modules. These swarms have overwhelmed regional defences and even struck a British base in Cyprus in March 2026, while NATO intercepted three Iranian ballistic missiles that entered Turkish airspace. In response, Roketsan is advancing the “Tayfun” (Typhoon) missile family. The flagship Tayfun Block 4 is a hypersonic ballistic missile designed to pierce advanced air‑defence layers at extreme speeds. When pressed for specifics, Ikinci declined to disclose the exact range, noting only that it is “sufficient.” Strategically, Turkey is shifting away from Western dependence toward an “Eastern” partnership model. Roketsan now offers joint production and technology‑development agreements, establishing co‑located facilities and R&D centres across the Middle East, Far East and Europe. Qatar has been cited as a flagship example of this collaborative approach. Roketsan has identified five priority product lines to meet rising global demand: Long‑range ballistic and cruise missiles. Advanced air‑defence systems, including “Steel Dome”, Hisar‑A, Hisar‑O and Siper. Submarine‑launched cruise missiles leveraging the AKYA system. Smart micro‑munitions for armed drones. Long‑range air‑to‑air missiles, a capability highlighted by the recent India‑Pakistan clash. The timing is critical. Ongoing conflicts have depleted the stockpiles of high‑end air‑defence assets worldwide. During the US‑Israel‑Iran confrontation, the United States relied heavily on Patriot and THAAD systems, raising concerns that interceptor inventories could run low. Gulf states, which have logged over 1,000 drone sightings in their airspace, are actively seeking alternative solutions—an opening that Turkey’s self‑sufficient supply chain is poised to fill. Analysts warn that even major powers like the United States will need years to rebuild their air‑defence inventories due to the complexity of production. Turkey’s claim of near‑complete domestic manufacturing positions it as a ready supplier for nations eager to diversify away from traditional Western sources. As demand for missiles and drones surges, Roketsan is reinvesting its revenues into expanding production infrastructure, aiming to cement its place among the world’s elite defence exporters.